Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

3rd Global Summit on Heart and Cardiovascular Care 2026

its legacy of excellence, Heart Congress 2026 will serve as a vibrant platform for cross-disciplinary dialogue on the latest innovations in cardiovascular research, digital health, and preventive medicine. Through forward-thinking discussions and...

VietPharma&Tech 2026

Exhibition & Convention Center (SECC). The exhibition focuses on introducing outstanding achievements and advances, the latest technology and products in the field of pharmaceutical manufacturing,laboratory analytical equipment…inVietnam and the...

NextGen Pharma 2026

NextGen Pharma, a premier global forum dedicated to exploring the latest innovations, emerging technologies, and future-focused strategies in the pharmaceutical industry. NextGen Pharma, a premier global forum dedicated to exploring the latest...

PHC Launched MTR-OPC1-PW Interface Board in September to Strengthen Data Linkage Between Equipment and Customer Systems

long-term preservation of samples and cell culture, as well as new solutions for the cell and gene therapy (CGT) field, testing and analysis equipment including POCT equipment, and in-vitro diagnostic reagents. Through these products and solutions,...

Abbott Launched the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at a Price Similar to Its Existing Similac Powdered Formula

are manufactured under rigorous quality and safety controls and meet or exceed industry regulations for infant formula testing. About Similac® Similac has been feeding babies for more than 100 years. Backed by Abbott's science and research, Similac...

Choose Health Launches Comprehensive At-Home Liver Function Test Featuring 20+ Biomarkers and Clinical Risk Scores

Choose Health, an at-home blood testing company, announced the launch of the Comprehensive Liver Function Test, a self-collection blood test measuring 20+ liver health markers for a disease that affects roughly one third of U.S. adults but remains...

Abbott receives FDA authorization for the world’s first dual glucose-ketone sensing technology for people with diabetes

DKA can progress within hours and, if left untreated, can lead to coma or death.4 While clinical guidance is to test ketones during illness or periods of elevated glucose, the majority of people do not have access to a blood ketone meter at home5...

U.S. FDA Approves Ziihera® (zanidatamab-hrii), With or Without Tislelizumab Plus Chemotherapy, for the First-Line Treatment of HER2-Positive Advanced Gastroesophageal Adenocarcinoma

HER2+ GEA," said Geoffrey Ku, M.D., HERIZON-GEA-01 study co-author and associate attending physician on the Gastrointestinal Oncology Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center. "Importantly, similar outcomes...

Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma

The distribution and availability of their WaterClear THC™ product in the UK market is a significant achievement and a testament to the company’s ambition, innovation and commitment to individualised patient healthcare. Enterprise Ireland is proud...

PanTRKare™ Is Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

with NTRK fusion‑positive solid tumors. As the original companion diagnostic for Eratrectinib, PanTRKare™ addresses key testing challenges including the pan‑tumor distribution, low incidence and complex fusion patterns of NTRK1/2/3 fusions,...

Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories

learning to design optimal experiments and deliver better and faster results with automated closed-loop Design-Make-Test-Analyze-Learn workflows. Running these integrated workflows generates high-quality, reproducible, and AI-ready datasets that...

Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models

Systems, or NAMs, have a bright future, and will be increasingly adopted in drug discovery, development and preclinical testing.” The MIMETAS portfolio includes the OrganoPlate platform for organ-on-a-chip research, OrganoReady® tissue and organoid...

Triquetra Health Launched BioActive Vitamin B1™—the First Complete B1 Activation System with a 600 mg Research-Matched Dose and Full Cofactor Support

is delivered in vegetarian HPMC capsules, manufactured in FDA-registered, cGMP-certified facilities with third-party testing for purity, potency, and safety. About Triquetra Health Triquetra Health develops clinically-validated supplements for...

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

health. Its flagship microbiome formulas are developed with rigorous scientific research and product-level clinical testing to provide health benefits across various body systems via the Gut-X Axis.

InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of the Worldwide Launch of Its Non-Injectable Peptide Platform

by enabling active compounds to dissolve through the oral mucosa, supporting efficient absorption while bypassing gastrointestinal degradation. The platform was recently validated through a double-blinded pharmacokinetic (PK) study demonstrating...

FDA Clears Roche's cobas® BV/CV Assay, Enabling Fast and Highly Accurate Diagnosis of Vaginitis

(FDA) 510(k) clearance for its cobas® BV/CV (Bacterial vaginosis/Candida vaginitis) assay. This molecular diagnostic test provides results for both Bacterial vaginosis (BV) and Candida vaginitis (CV) from a single vaginal swab sample. It enables...

China Approves Haisco's Class 1 Innovative Drug, Ciprocopan Succinate Tablets, Providing a New Treatment Option for Patients with PNH

focused on key therapeutic areas, including anesthesia and pain management, chronic and metabolic diseases, gastrointestinal and liver diseases, respiratory diseases, autoimmune diseases, and oncology. Annual R&D investment has exceeded RMB 1...

Hologic’s Aptima® HPV Test Receives Expanded CE-IVDR Mark to Include Self-Collected Samples for Cervical Cancer Screening

marking in the European Union and the UK and is now approved for self-collected vaginal samples using the Aptima Multitest Specimen Collection Kit. Cervical cancer is the fourth most common cancer in women but is largely preventable through HPV...

BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia Accepted by the U.S. Food and Drug Administration

gene mutation. The worldwide incidence rate of achondroplasia is about one in 25,000 live births. VOXZOGO is being tested in children whose growth plates are still "open," typically those under 18 years of age. Approximately 25% of people with...

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. announce the development and validation of a DOT-like drug-test panel for breath testing. The validated laboratory method expands Omega's breath-testing capability beyond cannabinoids and...